Lexaria Biosciences Corp. (OTCQX:LXRP) (CSE:LXX) represents a compelling opportunity in the burgeoning cannabis industry. By building an intellectual property portfolio early on, the company hopes to create significant barriers to entry for its DehydraTECH™ platform as well as open the door to royalty revenue from licensing agreements. Investors may want to keep a close eye on the stock given these developments.